As of February 18, we're $15,900 in the red for the quarter. Donate here to support this vital work
Subscribe here and join the 13,823 subscribers to our free weekly newsletter

In Germany, a Better Vaccine for Politicians?
Key Excerpts from Article on Website of Time magazine


Time magazine, October 27, 2009
Posted: November 19th, 2009
http://www.time.com/time/health/article/0,8599,1932366,00.ht...

As Germany launched its mass-vaccination program against the H1N1 flu virus on Monday, the government found itself fending off accusations of favoritism because it was offering one vaccine believed to have fewer side effects to civil servants, politicians and soldiers, and another, potentially riskier vaccine to everyone else. The German government prepared for its mass-vaccination campaign earlier this year by ordering 50 million doses of the Pandemrix vaccine. The vaccine, manufactured by GlaxoSmithKline, contains an immunity-enhancing chemical compound, known as an adjuvant, whose side effects are not yet entirely known. The Interior Ministry confirmed that it had ordered a different vaccine, Celvapan, for government officials and the military. Celvapan, which is made by U.S. pharmaceutical giant Baxter, does not contain an adjuvant and is believed to have fewer side effects.

Note: For a revealing article exposing more on this critical issue, click here. Other thoroughly researched articles suggesting a major cover-up around the swine flu vaccine are available here.


Latest News


Key News Articles from Years Past